Jim Anderson
Analyst · Charlie Anderson from Dougherty & Company
Yeah, thanks, Charlie. So first of all, in the SG&A, yeah, we had put out a long term target of 15% of revenue. We made some nice progress on that from Q1 to Q2. In fact, that we made a faster progress than Sherri or I had anticipated. And so that was good, we have a number of actions in place that we actually started to drive in Q1 in terms of actions to reduce SG&A expenses. I wouldn't point any one particular factor, it's just a number of different things that we're driving within that category. And there were a couple of those actions that just yielded benefit quicker than we had originally anticipated. So that's good to see, we remain committed to getting SG&A to that 15% level. That'll take time. It'll be a combination of direct cost reductions, but also scaling into our revenue as revenue grows, we’ll scale into it. And so it's a combination of both, but we expect to continue to make incremental progress towards that 15% goal.And now on R&D, our target is 20%. That's our long term target, we are running underneath 20% right now. The way I would characterize that is, if you look over the last few quarters, certainly since I started last year, late last year, and when our new Head of R&D and new Head of Marketing came on, in the back half of last year, one of our areas that we focused on right away was in driving just what I would call better efficiency within R&D or better productivity, just making sure that our existing R&D spend was optimized for the best ROI. And so that was our initial focus, because before we add on additional spending to R&D, we want to be convinced that the spending that we have is fully optimized.And so we went through a lot of work over the prior quarters to trim out projects that we thought were low ROI and reinvest that investment back into projects that are higher ROI. And so that's really been our focus over the last two to three quarters. And now that we're through with that, I would expect now R&D to start to incrementally grow from here. And we'll do that very judiciously and carefully. But we would expect R&D to tick back up, for instance, from Q2 to Q3. And as we continue to invest in the roadmap and ensure that we've got a steady beat rate of new innovation and new products for our customers.Hopefully, that's helpful, Charlie, and I think you had a follow up.